AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7910133 — intervention group
Group type: EXPERIMENTAL
Intervention: NAAGA and Placebo
Number of subjects: 17
Study 7910133 — intervention group
Group type: EXPERIMENTAL
Intervention: NAAGA
Number of subjects: 17
Study 3033182 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 40
Study 3033182 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 40
Study 3033182 — intervention group
Group type: COMPARATOR
Intervention: Captopril and Enalapril
Number of subjects: 40
Study 30414753 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Attraction to Physical Activity (CAPA) Scale
Number of subjects: 30
Study 30268163 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide/oxygen mixture
Number of subjects: 90
Study 30268163 — intervention group
Group type: COMPARATOR
Intervention: Oxygen (control)
Number of subjects: 90
Study 27096623 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg·kg‐1)
Number of subjects: 18
Study 27096623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 24518532 — intervention group
Group type: EXPERIMENTAL
Intervention: Yo Puedo intervention (conditional cash transfers and life skills sessions)
Number of subjects: 162
Study 24518532 — intervention group
Group type: COMPARATOR
Intervention: Standard services control arm
Number of subjects: 162
Study 22147786 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir (500 mg twice daily)
Number of subjects: 148
Study 22147786 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 19493958 — intervention group
Group type: EXPERIMENTAL
Intervention: modafinil (300 mg)
Number of subjects: 12
Study 19493958 — intervention group
Group type: EXPERIMENTAL
Intervention: prazosin (3 mg)
Number of subjects: 12
Study 19493958 — intervention group
Group type: EXPERIMENTAL
Intervention: modafinil (300 mg) and prazosin (3 mg) together
Number of subjects: 12
Study 19493958 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 18207336 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Interventions (BIs)
Number of subjects: 408
Study 16805932 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 120
Study 16805932 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 1.25 mg
Number of subjects: 120
Study 16805932 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 120
Study 12815555 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetholone (50 mg bid)
Number of subjects: 89
Study 12815555 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetholone (50 mg tid)
Number of subjects: 89
Study 12815555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 10886233 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 24
Study 10886233 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone
Number of subjects: 24
Study 10886233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 8644400 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stockings (pressure effect of 54 mmHg)
Number of subjects: 30
Study 8644400 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stockings)
Number of subjects: 30
Study 8644400 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stockings
Number of subjects: 30
Study 31893951 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix‐associated autologous chondrocyte implantation (ACI)
Number of subjects: 102
Study 31893951 — intervention group
Group type: COMPARATOR
Intervention: Microfracture (MF)
Number of subjects: 102
Study 30501521 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic suggestions during pre-surgery visit and audio recording during surgery
Number of subjects: 95
Study 30501521 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic suggestions
Number of subjects: 95
Study 30501521 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 95
Study 28029347 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical nonfiction books
Number of subjects: 0
Study 28029347 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmedical fiction books
Number of subjects: 0
Study 28029347 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified what intervention was used)
Number of subjects: 0
Study 24570989 — intervention group
Group type: EXPERIMENTAL
Intervention: Machined neck implants (group 1)
Number of subjects: 40
Study 24570989 — intervention group
Group type: COMPARATOR
Intervention: Rough, grooved neck implants (group 2)
Number of subjects: 40
Study 22275251 — intervention group
Group type: EXPERIMENTAL
Intervention: Probable RBD (pRBD(+))
Number of subjects: 651
Study 22275251 — intervention group
Group type: COMPARATOR
Intervention: Control group (pRBD(-))
Number of subjects: 651
Study 21550314 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting
Number of subjects: 2502
Study 21550314 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy
Number of subjects: 2502
Study 17549891 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasopressin (1‐desamino‐8‐D‐arginin‐vasopressin)
Number of subjects: 26
Study 16117817 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine (50 mg)
Number of subjects: 8
Study 16117817 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 12372132 — intervention group
Group type: EXPERIMENTAL
Intervention: 180 mg Fexofenadine (FEX)
Number of subjects: 49
Study 12372132 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg Desloratadine (DL)
Number of subjects: 49
Study 12372132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 10535855 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 2 g daily
Number of subjects: 41
Study 10535855 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporin A (CSA) to achieve whole blood trough levels of 120‐150 ng/ml
Number of subjects: 41
Study 8001386 — intervention group
Group type: COMPARATOR
Intervention: Upper access sites (subclavian or internal jugular veins)
Number of subjects: 45
Study 8001386 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower access site (femoral vein)
Number of subjects: 45
Study 2187169 — intervention group
Group type: EXPERIMENTAL
Intervention: Defibrotide (400 mg b.i.d. IM from the day before operation to the 7th postoperative day, n = 60)
Number of subjects: 120
Study 2187169 — intervention group
Group type: COMPARATOR
Intervention: Calcium heparin (5000 IU t.i.d. SC from the operation to the 7th postoperative day, n = 70)
Number of subjects: 120
Study 382082 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid
Number of subjects: 10
Study 382082 — intervention group
Group type: COMPARATOR
Intervention: 10% glucose
Number of subjects: 10
Study 31866211 — intervention group
Group type: EXPERIMENTAL
Intervention: Health for Hearts United intervention (3 treatment churches)
Number of subjects: 211
Study 31866211 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (3 churches)
Number of subjects: 211
Study 31519177 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous kyphoplasty (PKP)
Number of subjects: 0
Study 31519177 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-segmental fixation combined with vertebroplasty (SSF + VP)
Number of subjects: 0
Study 31519177 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 29019873 — intervention group
Group type: COMPARATOR
Intervention: 3D mapping system without x-ray (Group 1)
Number of subjects: 342
Study 29019873 — intervention group
Group type: EXPERIMENTAL
Intervention: x-ray and 3D mapping system (Group 2)
Number of subjects: 342
Study 25858200 — intervention group
Group type: EXPERIMENTAL
Intervention: Video clip on a smart phone for communication skills training
Number of subjects: 87
Study 25858200 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 87
Study 24058089 — intervention group
Group type: EXPERIMENTAL
Intervention: Tea-flavor liquor (TFL)
Number of subjects: 16
Study 24058089 — intervention group
Group type: COMPARATOR
Intervention: Water control (WC)
Number of subjects: 16
Study 24058089 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese liquor (TCL)
Number of subjects: 16
Study 20830646 — intervention group
Group type: EXPERIMENTAL
Intervention: Action plans
Number of subjects: 1273
Study 20830646 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping plans
Number of subjects: 1273
Study 20830646 — intervention group
Group type: COMPARATOR
Intervention: Control group (no action plans or coping plans)
Number of subjects: 1273
Study 19242485 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ascorbic acid and oral ibuprofen for 3 days
Number of subjects: 60
Study 19242485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 16445331 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy and 35 minutes of CPM applications daily
Number of subjects: 81
Study 16445331 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy and 2 hours of CPM applications daily
Number of subjects: 81
Study 16445331 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy only
Number of subjects: 81
Study 15540744 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal laser stimulation of the posterior tibial nerve, performed daily for 30 seconds over the SP6 acupuncture point for 12 weeks
Number of subjects: 56
Study 15540744 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham device)
Number of subjects: 56
Study 15540744 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment and control groups
Number of subjects: 56
Study 11236073 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine add on therapy to haloperidol 5 mg
Number of subjects: 30
Study 11236073 — intervention group
Group type: COMPARATOR
Intervention: Placebo add on therapy to haloperidol 5 mg
Number of subjects: 30
Study 9286889 — intervention group
Group type: EXPERIMENTAL
Intervention: DDAVP (0.3 microg/kg in 100 ml normal saline)
Number of subjects: 21
Study 9286889 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 21
Study 8361794 — intervention group
Group type: EXPERIMENTAL
Intervention: High-iron content premature formula (15 mg/L)
Number of subjects: 3
Study 8361794 — intervention group
Group type: COMPARATOR
Intervention: Low-iron content premature formula (3 mg/L)
Number of subjects: 3
Study 8361794 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk mixed with liquid fortifier (1.7 mg/L)
Number of subjects: 3
Study 3731212 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline (6 mg/kg loading dose on day 1, 4 mg/kg/day for 3 days)
Number of subjects: 25
Study 3731212 — intervention group
Group type: COMPARATOR
Intervention: Control (no aminophylline treatment)
Number of subjects: 25
Study 29310142 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncephalic presentation
Number of subjects: 1943
Study 29310142 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncephalic presentation via cesarean delivery
Number of subjects: 1943
Study 29310142 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncephalic presentation via vaginal delivery
Number of subjects: 1943
Study 29310142 — intervention group
Group type: COMPARATOR
Intervention: Cephalic presentation
Number of subjects: 1943
Study 25632805 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 12
Study 25632805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 23656848 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion (300 mg/d)
Number of subjects: 61
Study 23656848 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 19812581 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) at 20 p.p.m. decreasing to 2 p.p.m. for 24 days
Number of subjects: 102
Study 19812581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 18782206 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate catheterization (no delay group)
Number of subjects: 73
Study 18782206 — intervention group
Group type: COMPARATOR
Intervention: 2 min delay catheterization (2 min delay group)
Number of subjects: 73
Study 16085617 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia head
Number of subjects: 52
Study 16085617 — intervention group
Group type: COMPARATOR
Intervention: Cobalt-chromium head
Number of subjects: 52
Study 11915394 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-controlled anesthetic delivery system
Number of subjects: 150
Study 11915394 — intervention group
Group type: COMPARATOR
Intervention: Standard injections
Number of subjects: 150
Study 10396711 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 50 mg
Number of subjects: 30
Study 10396711 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 100 mg
Number of subjects: 30
Study 10396711 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 150 mg
Number of subjects: 30
Study 10396711 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 200 mg
Number of subjects: 30
Study 10396711 — intervention group
Group type: COMPARATOR
Intervention: Propofol hypnosis
Number of subjects: 30
Study 7484046 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml of 1% prilocaine plus 6 mg morphine sulfate in 10 ml of 0.9% sodium chloride (P/M group)
Number of subjects: 20
Study 7484046 — intervention group
Group type: COMPARATOR
Intervention: 30 ml of 1% prilocaine plus 10 ml of 0.9% sodium chloride (P group)
Number of subjects: 20
Study 2292535 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil
Number of subjects: 2448
Study 2292535 — intervention group
Group type: COMPARATOR
Intervention: Comparative antibiotics
Number of subjects: 2448
Study 12336988 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestasert
Number of subjects: 382
Study 12336988 — intervention group
Group type: COMPARATOR
Intervention: CuT 200
Number of subjects: 382
Study 30672304 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy
Number of subjects: 40
Study 30672304 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 40
Study 30932841 — intervention group
Group type: EXPERIMENTAL
Intervention: TPAD with a Closed-Loop Controller
Number of subjects: 0
Study 30932841 — intervention group
Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 0
Study 28111044 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial infrahepatic inferior vena cava clamping
Number of subjects: 90
Study 28111044 — intervention group
Group type: COMPARATOR
Intervention: Nonclamping
Number of subjects: 90
Study 26059872 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits with a general practitioner and municipal nurse within seven days of discharge focusing on medication, rehabilitation plan, functional level, and need for further health care initiatives.
Number of subjects: 531
Study 26059872 — intervention group
Group type: COMPARATOR
Intervention: Standard health care services (Control).
Number of subjects: 531
Study 26059872 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits with a general practitioner and municipal nurse.
Number of subjects: 531
Study 23463656 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 infusion for 2 hours
Number of subjects: 12
Study 21483704 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavior therapy (ICBT), n=64
Number of subjects: 126
Study 21483704 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral group therapy (CBGT), n=62
Number of subjects: 126
Study 21483704 — intervention group
Group type: EXPERIMENTAL
Intervention: ICBT
Number of subjects: 126
Study 21483704 — intervention group
Group type: EXPERIMENTAL
Intervention: ICBT and CBGT
Number of subjects: 126
Study 18083322 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy for pregnant substance users (MET‐PS)
Number of subjects: 200
Study 18083322 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 200
Study 17228550 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with antidepressants
Number of subjects: 0
Study 17228550 — intervention group
Group type: EXPERIMENTAL
Intervention: Asking about self-harm
Number of subjects: 0
Study 12918647 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week hydration intervention
Number of subjects: 49
Study 12918647 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hydration intervention)
Number of subjects: 49
Study 11737501 — intervention group
Group type: EXPERIMENTAL
Intervention: Development work including educational strand with open learning research materials and tutorial support; clinical research project development support with project development awards
Number of subjects: 473
Study 9007493 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 IU r‐HuEpo/kg, subcutaneously thrice weekly
Number of subjects: 32
Study 9007493 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 IU r‐HuEpo/kg, subcutaneously thrice weekly
Number of subjects: 32
Study 9007493 — intervention group
Group type: COMPARATOR
Intervention: Commercial cow's milk protein
Number of subjects: 32
Study 9007493 — intervention group
Group type: COMPARATOR
Intervention: Human milk protein
Number of subjects: 32
Study 8064580 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise training
Number of subjects: 35
Study 8064580 — intervention group
Group type: COMPARATOR
Intervention: Nontraining (control)
Number of subjects: 35
Study 3330115 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg tid)
Number of subjects: 20
Study 3330115 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 29152749 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nasal anesthetic (0.4 mL of 2% viscous lidocaine hydrochloride)
Number of subjects: 20
Study 29152749 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nonanesthetic lubricant)
Number of subjects: 20
Study 29152749 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nasal anesthetic
Number of subjects: 20
Study 27503659 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg REL plus 500 mg IMI
Number of subjects: 351
Study 27503659 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg REL plus 500 mg IMI
Number of subjects: 351
Study 27503659 — intervention group
Group type: COMPARATOR
Intervention: 500 mg IMI alone
Number of subjects: 351
Study 23860624 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-tailored intervention (age-specific strategy training and short-term emotional focus)
Number of subjects: 386
Study 23860624 — intervention group
Group type: COMPARATOR
Intervention: Age-neutral intervention
Number of subjects: 386
Study 22497773 — intervention group
Group type: EXPERIMENTAL
Intervention: ORIF using two point fixation by miniplates
Number of subjects: 100
Study 22497773 — intervention group
Group type: COMPARATOR
Intervention: ORIF using three point fixation by miniplates
Number of subjects: 100
Study 20133012 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 2.5% cream
Number of subjects: 490
Study 20133012 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 3.75% cream
Number of subjects: 490
Study 20133012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 490
Study 18078737 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower levels of anger control
Number of subjects: 98
Study 18078737 — intervention group
Group type: EXPERIMENTAL
Intervention: Anger control variable
Number of subjects: 98
Study 18078737 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced cortisol secretion
Number of subjects: 98
Study 15843940 — intervention group
Group type: EXPERIMENTAL
Intervention: Single purse-string CSM (group 1)
Number of subjects: 100
Study 15843940 — intervention group
Group type: EXPERIMENTAL
Intervention: Double purse-string CSM (group 2)
Number of subjects: 100
Study 14625812 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha 2b (3 x 3 MIU sc weekly) and oral ribavirin (1000/1200 mg po daily) for 24 weeks
Number of subjects: 37
Study 14625812 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha 2b (3 x 3 MIU sc weekly) and oral ribavirin (1000/1200 mg po daily) for 48 weeks
Number of subjects: 37
Study 10824642 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal splinting (Breathe‐Right)
Number of subjects: 12
Study 10824642 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (maximal oxygen uptake treadmill test)
Number of subjects: 12
Study 10824642 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined effects of exercise and nasal splinting
Number of subjects: 12
Study 8690831 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 204,636 (75 to 750 mg daily)
Number of subjects: 109
Study 8690831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 1978490 — intervention group
Group type: EXPERIMENTAL
Intervention: Remoxipride alone
Number of subjects: 12
Study 1978490 — intervention group
Group type: COMPARATOR
Intervention: Ethanol
Number of subjects: 12
Study 1978490 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 12
Study 1978490 — intervention group
Group type: EXPERIMENTAL
Intervention: Remoxipride combined with ethanol
Number of subjects: 12
Study 1978490 — intervention group
Group type: EXPERIMENTAL
Intervention: Remoxipride combined with diazepam
Number of subjects: 12
Study 264798 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial irradiation combined with a 3-year course of multiple drug systemic chemotherapy
Number of subjects: 0
Study 264798 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive cranial irradiation
Number of subjects: 0
Study 264798 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose palliative irradiation
Number of subjects: 0
Study 264798 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0
Study 264798 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple agent chemotherapy and preventive meningeal irradiation
Number of subjects: 0
Study 264798 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide therapy
Number of subjects: 0
Study 30580905 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosexual rehabilitation booklet
Number of subjects: 82